Study of anti-inflammatory treatment for migraine in rheumatology patients
Part of Brain & nervous system clinical trials.
This trial looks at whether anti-IL-6 treatments, already used for rheumatological conditions, can also help reduce migraines. If you have both a rheumatological condition and migraines, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have taken an anti-IL-6 or anti-TNF medication for at least 3 months (these are biologic drugs that reduce inflammation)
- You have been diagnosed with migraine or have migraine symptoms
- Your biologic treatment is not for giant cell arteritis (a specific type of blood vessel inflammation)
- You are able to communicate verbally and are affiliated with the French national health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests whether a combination of physical therapy techniques can reduce migraine symptoms. It may help people whose migraines are not caused by other conditions.
This trial tests whether hands-on osteopathic treatment can help reduce migraines. If you're an adult aged 18–50 with frequent migraines, you might benefit from seeing if this non-drug approach eases your symptoms.
This study looks at thinking abilities and psychological factors in people with migraines. It aims to understand how migraine affects memory, attention, and emotions.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.